Senestech (NASDAQ:SNES) Major Shareholder Buys 376,552 Shares of Company Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 376,552 shares of the stock in a transaction dated Monday, October 19th. The stock was bought at an average cost of $0.70 per share, with a total value of $263,586.40. Following the completion of the purchase, the insider owned 2,063,098 shares in the company, valued at $1,444,168.60. The trade was a 22.33% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, October 16th, Glenbrook Capital Management purchased 181,252 shares of Senestech stock. The stock was purchased at an average price of $0.63 per share, for a total transaction of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The shares were purchased at an average cost of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management acquired 15,000 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $19,500.00.

Senestech Trading Up 8.2%

NASDAQ:SNES traded up $0.05 during trading hours on Monday, hitting $0.70. The stock had a trading volume of 1,245,150 shares, compared to its average volume of 375,681. Senestech, Inc. has a one year low of $0.55 and a one year high of $4.04. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.81 and a current ratio of 6.78. The company has a market cap of $3.79 million, a price-to-earnings ratio of -0.51 and a beta of 0.25. The business’s 50 day moving average is $0.93 and its 200-day moving average is $1.34.

Senestech (NASDAQ:SNES) last posted its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.02. The company had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. Sell-side analysts anticipate that Senestech, Inc. will post -1.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Senestech

A hedge fund recently bought a new position in Senestech stock. Diversify Wealth Management LLC acquired a new stake in shares of Senestech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned approximately 0.36% of Senestech at the end of the most recent reporting period. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Senestech has a consensus rating of “Sell”.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.